BARDA and Hememics Collaborate to Develop Rapid Diagnostic to Identify SARS-CoV-2
BARDA is collaborating with Hememics Biotechnologies, Inc. on the development of a rapid, Bluetooth-connected SARS-CoV-2 diagnostic test. The test is ...
BARDA is collaborating with Hememics Biotechnologies, Inc. on the development of a rapid, Bluetooth-connected SARS-CoV-2 diagnostic test. The test is ...
BARDA and Sanofi Pasteur, the vaccines global business unit of Sanofi, are expanding their collaboration to develop a SARS-CoV-2 vaccine. ...
Regeneron Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a new ...
Abbott announced today the launch of its third COVID-19 test, a lab-based serology blood test for the detection of the ...
The U.S. Department of Health and Human Services (HHS) will collaborate with multiple non-government organizations on the development of convalescent ...
BARDA and Vela Diagnostics USA, Inc. are entering into a partnership to develop a rapid diagnostic test for use on ...
Ridgeback Biotherapeutics announced clearance by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for an orally available antiviral compound, ...
BARDA is collaborating with DiaSorin to develop a clinical laboratory test to identify people who have been infected with the ...
Eli Lilly announced it has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part ...
The Lab-in-Cartridge rapid test, based on Professor Toumazou’s DnaNudge consumer DNA testing innovation, has been clinically validated after a successful ...
The U.S. Department of Health and Human Services (HHS) announced an agreement with DuPont to expedite the delivery of critical ...
The Department of Health and Human Services announced the second contract for ventilator production rated under the Defense Production Act ...
Arrakis Therapeutics, a biopharmaceutical company working on the discovery of a new class of small molecule medicines that directly target ...
BARDA has partnered with Nanomix, Inc. on the development of a COVID-19 rapid mobile test to diagnose COVID-19 infections with ...
Ridgeback Biotherapeutics LP, a closely held biotechnology company, and Drug Innovations at Emory (DRIVE), LLC, a not-for-profit biotechnology company wholly owned by Emory ...
INOVIO Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has accepted the company's Investigational New Drug (IND) ...
BARDA expanded an existing partnership with Genentech, part of Roche Group and headquartered in South San Francisco, to accelerate a Phase ...
Amgen and Adaptive Biotechnologies announced a collaboration aimed at combing expertise to discover and develop fully human neutralizing antibodies targeting ...
Emergent BioSolutions Inc. announced today that it has entered into a formal partnership with the U.S. government to expedite development of a ...
Celularity Inc., a clinical-stage company developing allogeneic cellular therapies from human placentas, today announced the U.S. Food and Drug Administration ...